Pluto Biosciences

Pluto Biosciences has developed an AI-powered, collaborative bioinformatics platform specifically for translational and preclinical research teams in pharma, academia, and CROs. The company's core offering, the Pluto Bio platform, centralizes multi-omics data, provides no-code analysis tools and visualization canvases, and facilitates real-time collaboration to streamline the path from experimental data to review-ready evidence. With a recent $3.6M funding round, Pluto is positioned to expand its platform's capabilities and market reach, targeting the growing need for integrated data analysis solutions in the era of complex, multi-modal biological data.

Cloud-based, no-code collaborative platform for multi-omics data management, analysis, and visualization. Supports single-cell RNA-seq, bulk RNA-seq, proteomics, metabolomics, spatial transcriptomics, and other assays with AI/ML-powered analysis tools and end-to-end traceability.

Competes with large commercial bioinformatics software providers (e.g., Qiagen, Partek/Revvity), open-source tool ecosystems (R/Bioconductor, Python), and a growing number of venture-backed startups offering niche or broad bioinformatics platforms. Differentiation hinges on a specific focus on translational team collaboration, a no-code interface, and multi-omics integration.